SCHEMBL11577926

SCHEMBL11577926

CC(C)Oc1ccc(CC(=O)c2cc(OC(C)C)c(OC(C)C)cc2CC(=O)O)cc1OC(C)C

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 4/20 0.70
▸ NPSR1 Q6W5P4 1/20 0.70
▸ RXRA P19793 1/20 0.45
▸ RXRB P28702 1/20 0.45
▸ RXRG P48443 1/20 0.45
▸ LMNA P02545 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ TSHR P16473 1/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ S1PR1 P21453 1/20 0.40
▸ CA5A P35218 1/20 0.39
▸ FFAR4 Q5NUL3 2/20 0.39
▸ FFAR1 O14842 1/20 0.39
▸ P2RX3 P56373 2/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11577822 0.84 RXRA (0.58) GAANPSR1RXRARXRBRXRG
SCHEMBL11576174 0.82 GAA (1.00) GAANPSR1LMNASMN1; SMN2HTT
SCHEMBL11577453 0.80 GAA (0.71) GAANPSR1RXRARXRBRXRG
SCHEMBL2392443 0.77 CA5A (0.62) GAANPSR1RXRARXRBRXRG
SCHEMBL19543009 0.77 RXRA (0.44) GAANPSR1RXRARXRBRXRG
SCHEMBL11577685 0.77 GAA (0.67) GAANPSR1LMNASMN1; SMN2HTT
SCHEMBL5046347 0.75 RXRA (0.52) GAARXRARXRBRXRGLMNA
SCHEMBL8072663 0.72 GAA (0.50) GAANPSR1RXRARXRBRXRG
SCHEMBL7319318 0.71 ALDH1A1 (0.45) RXRARXRBRXRGLMNASMN1; SMN2
SCHEMBL7825089 0.70 GAA (0.76) GAANPSR1LMNASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4075344-A 3-ALKOXYISOQUINOLINES FOR HYPOTENSIVE AND VASODILATING EFFECTS MEAD JOHNSON & COMPANY (US) 1978-02-21 — — US disclosed
US-4015006-A 3(2H)-Isoquinolones therapeutic process MEAD JOHNSON & COMPANY (US) 1977-03-29 — — US disclosed
Send feedback